Global Pharmaceutical Products and CMO Market Size, Status and Forecast 2024-2031

Report ID: 918340 | Published Date: Jan 2025 | No. of Page: 120 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Active Pharmaceutical Ingredient (API)
        1.2.3 Finished Dosage Form (FDF)
        1.2.4 Pharmaceutical Packaging
    1.3 Market by Application
        1.3.1 Global Pharmaceutical Products and CMO Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Specialty/Midsize
        1.3.3 Generics
        1.3.4 Big Pharma
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Pharmaceutical Products and CMO Market Perspective (2016-2027)
    2.2 Pharmaceutical Products and CMO Growth Trends by Regions
        2.2.1 Pharmaceutical Products and CMO Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Pharmaceutical Products and CMO Historic Market Share by Regions (2016-2021)
        2.2.3 Pharmaceutical Products and CMO Forecasted Market Size by Regions (2022-2027)
    2.3 Pharmaceutical Products and CMO Industry Dynamic
        2.3.1 Pharmaceutical Products and CMO Market Trends
        2.3.2 Pharmaceutical Products and CMO Market Drivers
        2.3.3 Pharmaceutical Products and CMO Market Challenges
        2.3.4 Pharmaceutical Products and CMO Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Pharmaceutical Products and CMO Players by Revenue
        3.1.1 Global Top Pharmaceutical Products and CMO Players by Revenue (2016-2021)
        3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2016-2021)
    3.2 Global Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Pharmaceutical Products and CMO Revenue
    3.4 Global Pharmaceutical Products and CMO Market Concentration Ratio
        3.4.1 Global Pharmaceutical Products and CMO Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Products and CMO Revenue in 2020
    3.5 Pharmaceutical Products and CMO Key Players Head office and Area Served
    3.6 Key Players Pharmaceutical Products and CMO Product Solution and Service
    3.7 Date of Enter into Pharmaceutical Products and CMO Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmaceutical Products and CMO Breakdown Data by Type
    4.1 Global Pharmaceutical Products and CMO Historic Market Size by Type (2016-2021)
    4.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2022-2027)

5 Pharmaceutical Products and CMO Breakdown Data by Application
    5.1 Global Pharmaceutical Products and CMO Historic Market Size by Application (2016-2021)
    5.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Pharmaceutical Products and CMO Market Size (2016-2027)
    6.2 North America Pharmaceutical Products and CMO Market Size by Type
        6.2.1 North America Pharmaceutical Products and CMO Market Size by Type (2016-2021)
        6.2.2 North America Pharmaceutical Products and CMO Market Size by Type (2022-2027)
        6.2.3 North America Pharmaceutical Products and CMO Market Size by Type (2016-2027)
    6.3 North America Pharmaceutical Products and CMO Market Size by Application
        6.3.1 North America Pharmaceutical Products and CMO Market Size by Application (2016-2021)
        6.3.2 North America Pharmaceutical Products and CMO Market Size by Application (2022-2027)
        6.3.3 North America Pharmaceutical Products and CMO Market Size by Application (2016-2027)
    6.4 North America Pharmaceutical Products and CMO Market Size by Country
        6.4.1 North America Pharmaceutical Products and CMO Market Size by Country (2016-2021)
        6.4.2 North America Pharmaceutical Products and CMO Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Pharmaceutical Products and CMO Market Size (2016-2027)
    7.2 Europe Pharmaceutical Products and CMO Market Size by Type
        7.2.1 Europe Pharmaceutical Products and CMO Market Size by Type (2016-2021)
        7.2.2 Europe Pharmaceutical Products and CMO Market Size by Type (2022-2027)
        7.2.3 Europe Pharmaceutical Products and CMO Market Size by Type (2016-2027)
    7.3 Europe Pharmaceutical Products and CMO Market Size by Application
        7.3.1 Europe Pharmaceutical Products and CMO Market Size by Application (2016-2021)
        7.3.2 Europe Pharmaceutical Products and CMO Market Size by Application (2022-2027)
        7.3.3 Europe Pharmaceutical Products and CMO Market Size by Application (2016-2027)
    7.4 Europe Pharmaceutical Products and CMO Market Size by Country
        7.4.1 Europe Pharmaceutical Products and CMO Market Size by Country (2016-2021)
        7.4.2 Europe Pharmaceutical Products and CMO Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Pharmaceutical Products and CMO Market Size (2016-2027)
    8.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type
        8.2.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2016-2027)
    8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application
        8.3.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2016-2027)
    8.4 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region
        8.4.1 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Pharmaceutical Products and CMO Market Size (2016-2027)
    9.2 Latin America Pharmaceutical Products and CMO Market Size by Type
        9.2.1 Latin America Pharmaceutical Products and CMO Market Size by Type (2016-2021)
        9.2.2 Latin America Pharmaceutical Products and CMO Market Size by Type (2022-2027)
        9.2.3 Latin America Pharmaceutical Products and CMO Market Size by Type (2016-2027)
    9.3 Latin America Pharmaceutical Products and CMO Market Size by Application
        9.3.1 Latin America Pharmaceutical Products and CMO Market Size by Application (2016-2021)
        9.3.2 Latin America Pharmaceutical Products and CMO Market Size by Application (2022-2027)
        9.3.3 Latin America Pharmaceutical Products and CMO Market Size by Application (2016-2027)
    9.4 Latin America Pharmaceutical Products and CMO Market Size by Country
        9.4.1 Latin America Pharmaceutical Products and CMO Market Size by Country (2016-2021)
        9.4.2 Latin America Pharmaceutical Products and CMO Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Pharmaceutical Products and CMO Market Size (2016-2027)
    10.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type
        10.2.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2016-2027)
    10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application
        10.3.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2016-2027)
    10.4 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country
        10.4.1 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Catalent
        11.1.1 Catalent Company Details
        11.1.2 Catalent Business Overview
        11.1.3 Catalent Pharmaceutical Products and CMO Introduction
        11.1.4 Catalent Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.1.5 Catalent Recent Development
    11.2 DPx
        11.2.1 DPx Company Details
        11.2.2 DPx Business Overview
        11.2.3 DPx Pharmaceutical Products and CMO Introduction
        11.2.4 DPx Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.2.5 DPx Recent Development
    11.3 Lonza
        11.3.1 Lonza Company Details
        11.3.2 Lonza Business Overview
        11.3.3 Lonza Pharmaceutical Products and CMO Introduction
        11.3.4 Lonza Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.3.5 Lonza Recent Development
    11.4 Piramal Healthcare
        11.4.1 Piramal Healthcare Company Details
        11.4.2 Piramal Healthcare Business Overview
        11.4.3 Piramal Healthcare Pharmaceutical Products and CMO Introduction
        11.4.4 Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.4.5 Piramal Healthcare Recent Development
    11.5 Aenova
        11.5.1 Aenova Company Details
        11.5.2 Aenova Business Overview
        11.5.3 Aenova Pharmaceutical Products and CMO Introduction
        11.5.4 Aenova Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.5.5 Aenova Recent Development
    11.6 Jubilant
        11.6.1 Jubilant Company Details
        11.6.2 Jubilant Business Overview
        11.6.3 Jubilant Pharmaceutical Products and CMO Introduction
        11.6.4 Jubilant Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.6.5 Jubilant Recent Development
    11.7 Famar
        11.7.1 Famar Company Details
        11.7.2 Famar Business Overview
        11.7.3 Famar Pharmaceutical Products and CMO Introduction
        11.7.4 Famar Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.7.5 Famar Recent Development
    11.8 Boehringer Ingelheim
        11.8.1 Boehringer Ingelheim Company Details
        11.8.2 Boehringer Ingelheim Business Overview
        11.8.3 Boehringer Ingelheim Pharmaceutical Products and CMO Introduction
        11.8.4 Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.8.5 Boehringer Ingelheim Recent Development
    11.9 Fareva Holding
        11.9.1 Fareva Holding Company Details
        11.9.2 Fareva Holding Business Overview
        11.9.3 Fareva Holding Pharmaceutical Products and CMO Introduction
        11.9.4 Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.9.5 Fareva Holding Recent Development
    11.10 AbbVie
        11.10.1 AbbVie Company Details
        11.10.2 AbbVie Business Overview
        11.10.3 AbbVie Pharmaceutical Products and CMO Introduction
        11.10.4 AbbVie Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.10.5 AbbVie Recent Development
    11.11 Nipro Corp
        11.11.1 Nipro Corp Company Details
        11.11.2 Nipro Corp Business Overview
        11.11.3 Nipro Corp Pharmaceutical Products and CMO Introduction
        11.11.4 Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.11.5 Nipro Corp Recent Development
    11.12 Vetter
        11.12.1 Vetter Company Details
        11.12.2 Vetter Business Overview
        11.12.3 Vetter Pharmaceutical Products and CMO Introduction
        11.12.4 Vetter Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.12.5 Vetter Recent Development
    11.13 Sopharma
        11.13.1 Sopharma Company Details
        11.13.2 Sopharma Business Overview
        11.13.3 Sopharma Pharmaceutical Products and CMO Introduction
        11.13.4 Sopharma Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.13.5 Sopharma Recent Development
    11.14 Mylan (DPT Laboratories)
        11.14.1 Mylan (DPT Laboratories) Company Details
        11.14.2 Mylan (DPT Laboratories) Business Overview
        11.14.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Introduction
        11.14.4 Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.14.5 Mylan (DPT Laboratories) Recent Development
    11.15 Recipharm
        11.15.1 Recipharm Company Details
        11.15.2 Recipharm Business Overview
        11.15.3 Recipharm Pharmaceutical Products and CMO Introduction
        11.15.4 Recipharm Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.15.5 Recipharm Recent Development
    11.16 NextPharma Technologies
        11.16.1 NextPharma Technologies Company Details
        11.16.2 NextPharma Technologies Business Overview
        11.16.3 NextPharma Technologies Pharmaceutical Products and CMO Introduction
        11.16.4 NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.16.5 NextPharma Technologies Recent Development
    11.17 Dishman
        11.17.1 Dishman Company Details
        11.17.2 Dishman Business Overview
        11.17.3 Dishman Pharmaceutical Products and CMO Introduction
        11.17.4 Dishman Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.17.5 Dishman Recent Development
    11.18 Aesica
        11.18.1 Aesica Company Details
        11.18.2 Aesica Business Overview
        11.18.3 Aesica Pharmaceutical Products and CMO Introduction
        11.18.4 Aesica Revenue in Pharmaceutical Products and CMO Business (2016-2021)
        11.18.5 Aesica Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Active Pharmaceutical Ingredient (API)
    Table 3. Key Players of Finished Dosage Form (FDF)
    Table 4. Key Players of Pharmaceutical Packaging
    Table 5. Global Pharmaceutical Products and CMO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Pharmaceutical Products and CMO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Pharmaceutical Products and CMO Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Pharmaceutical Products and CMO Market Share by Regions (2016-2021)
    Table 9. Global Pharmaceutical Products and CMO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Pharmaceutical Products and CMO Market Share by Regions (2022-2027)
    Table 11. Pharmaceutical Products and CMO Market Trends
    Table 12. Pharmaceutical Products and CMO Market Drivers
    Table 13. Pharmaceutical Products and CMO Market Challenges
    Table 14. Pharmaceutical Products and CMO Market Restraints
    Table 15. Global Pharmaceutical Products and CMO Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Pharmaceutical Products and CMO Market Share by Players (2016-2021)
    Table 17. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Products and CMO as of 2020)
    Table 18. Ranking of Global Top Pharmaceutical Products and CMO Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Pharmaceutical Products and CMO Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Pharmaceutical Products and CMO Product Solution and Service
    Table 22. Date of Enter into Pharmaceutical Products and CMO Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2016-2021)
    Table 26. Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Pharmaceutical Products and CMO Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2016-2021)
    Table 30. Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Pharmaceutical Products and CMO Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Pharmaceutical Products and CMO Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Pharmaceutical Products and CMO Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Pharmaceutical Products and CMO Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Pharmaceutical Products and CMO Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Pharmaceutical Products and CMO Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Pharmaceutical Products and CMO Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Pharmaceutical Products and CMO Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Pharmaceutical Products and CMO Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Pharmaceutical Products and CMO Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Pharmaceutical Products and CMO Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Pharmaceutical Products and CMO Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Pharmaceutical Products and CMO Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Pharmaceutical Products and CMO Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Pharmaceutical Products and CMO Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Pharmaceutical Products and CMO Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Pharmaceutical Products and CMO Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Pharmaceutical Products and CMO Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Pharmaceutical Products and CMO Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Catalent Company Details
    Table 63. Catalent Business Overview
    Table 64. Catalent Pharmaceutical Products and CMO Product
    Table 65. Catalent Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 66. Catalent Recent Development
    Table 67. DPx Company Details
    Table 68. DPx Business Overview
    Table 69. DPx Pharmaceutical Products and CMO Product
    Table 70. DPx Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 71. DPx Recent Development
    Table 72. Lonza Company Details
    Table 73. Lonza Business Overview
    Table 74. Lonza Pharmaceutical Products and CMO Product
    Table 75. Lonza Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 76. Lonza Recent Development
    Table 77. Piramal Healthcare Company Details
    Table 78. Piramal Healthcare Business Overview
    Table 79. Piramal Healthcare Pharmaceutical Products and CMO Product
    Table 80. Piramal Healthcare Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 81. Piramal Healthcare Recent Development
    Table 82. Aenova Company Details
    Table 83. Aenova Business Overview
    Table 84. Aenova Pharmaceutical Products and CMO Product
    Table 85. Aenova Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 86. Aenova Recent Development
    Table 87. Jubilant Company Details
    Table 88. Jubilant Business Overview
    Table 89. Jubilant Pharmaceutical Products and CMO Product
    Table 90. Jubilant Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 91. Jubilant Recent Development
    Table 92. Famar Company Details
    Table 93. Famar Business Overview
    Table 94. Famar Pharmaceutical Products and CMO Product
    Table 95. Famar Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 96. Famar Recent Development
    Table 97. Boehringer Ingelheim Company Details
    Table 98. Boehringer Ingelheim Business Overview
    Table 99. Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 100. Boehringer Ingelheim Recent Development
    Table 101. Fareva Holding Company Details
    Table 102. Fareva Holding Business Overview
    Table 103. Fareva Holding Pharmaceutical Products and CMO Product
    Table 104. Fareva Holding Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 105. Fareva Holding Recent Development
    Table 106. AbbVie Company Details
    Table 107. AbbVie Business Overview
    Table 108. AbbVie Pharmaceutical Products and CMO Product
    Table 109. AbbVie Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 110. AbbVie Recent Development
    Table 111. Nipro Corp Company Details
    Table 112. Nipro Corp Business Overview
    Table 113. Nipro Corp Pharmaceutical Products and CMO Product
    Table 114. Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 115. Nipro Corp Recent Development
    Table 116. Vetter Company Details
    Table 117. Vetter Business Overview
    Table 118. Vetter Pharmaceutical Products and CMO Product
    Table 119. Vetter Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 120. Vetter Recent Development
    Table 121. Sopharma Company Details
    Table 122. Sopharma Business Overview
    Table 123. Sopharma Pharmaceutical Products and CMO Product
    Table 124. Sopharma Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 125. Sopharma Recent Development
    Table 126. Mylan (DPT Laboratories) Company Details
    Table 127. Mylan (DPT Laboratories) Business Overview
    Table 128. Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product
    Table 129. Mylan (DPT Laboratories) Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 130. Mylan (DPT Laboratories) Recent Development
    Table 131. Recipharm Company Details
    Table 132. Recipharm Business Overview
    Table 133. Recipharm Pharmaceutical Products and CMO Product
    Table 134. Recipharm Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 135. Recipharm Recent Development
    Table 136. NextPharma Technologies Company Details
    Table 137. NextPharma Technologies Business Overview
    Table 138. NextPharma Technologies Pharmaceutical Products and CMO Product
    Table 139. NextPharma Technologies Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 140. NextPharma Technologies Recent Development
    Table 141. Dishman Company Details
    Table 142. Dishman Business Overview
    Table 143. Dishman Pharmaceutical Products and CMO Product
    Table 144. Dishman Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 145. Dishman Recent Development
    Table 146. Aesica Company Details
    Table 147. Aesica Business Overview
    Table 148. Aesica Pharmaceutical Products and CMO Product
    Table 149. Aesica Revenue in Pharmaceutical Products and CMO Business (2016-2021) & (US$ Million)
    Table 150. Aesica Recent Development
    Table 151. Research Programs/Design for This Report
    Table 152. Key Data Information from Secondary Sources
    Table 153. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pharmaceutical Products and CMO Market Share by Type: 2020 VS 2027
    Figure 2. Active Pharmaceutical Ingredient (API) Features
    Figure 3. Finished Dosage Form (FDF) Features
    Figure 4. Pharmaceutical Packaging Features
    Figure 5. Global Pharmaceutical Products and CMO Market Share by Application: 2020 VS 2027
    Figure 6. Specialty/Midsize Case Studies
    Figure 7. Generics Case Studies
    Figure 8. Big Pharma Case Studies
    Figure 9. Others Case Studies
    Figure 10. Pharmaceutical Products and CMO Report Years Considered
    Figure 11. Global Pharmaceutical Products and CMO Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Pharmaceutical Products and CMO Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Pharmaceutical Products and CMO Market Share by Regions: 2020 VS 2027
    Figure 14. Global Pharmaceutical Products and CMO Market Share by Regions (2022-2027)
    Figure 15. Global Pharmaceutical Products and CMO Market Share by Players in 2020
    Figure 16. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Products and CMO as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Pharmaceutical Products and CMO Revenue in 2020
    Figure 18. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2016-2021)
    Figure 19. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2022-2027)
    Figure 20. North America Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Pharmaceutical Products and CMO Market Share by Type (2016-2027)
    Figure 22. North America Pharmaceutical Products and CMO Market Share by Application (2016-2027)
    Figure 23. North America Pharmaceutical Products and CMO Market Share by Country (2016-2027)
    Figure 24. United States Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Pharmaceutical Products and CMO Market Share by Type (2016-2027)
    Figure 28. Europe Pharmaceutical Products and CMO Market Share by Application (2016-2027)
    Figure 29. Europe Pharmaceutical Products and CMO Market Share by Country (2016-2027)
    Figure 30. Germany Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Pharmaceutical Products and CMO Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Pharmaceutical Products and CMO Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Pharmaceutical Products and CMO Market Share by Region (2016-2027)
    Figure 40. China Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Pharmaceutical Products and CMO Market Share by Type (2016-2027)
    Figure 48. Latin America Pharmaceutical Products and CMO Market Share by Application (2016-2027)
    Figure 49. Latin America Pharmaceutical Products and CMO Market Share by Country (2016-2027)
    Figure 50. Mexico Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Pharmaceutical Products and CMO Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Pharmaceutical Products and CMO Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Pharmaceutical Products and CMO Market Share by Country (2016-2027)
    Figure 56. Turkey Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Pharmaceutical Products and CMO Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Catalent Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 60. DPx Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 61. Lonza Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 62. Piramal Healthcare Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 63. Aenova Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 64. Jubilant Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 65. Famar Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 66. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 67. Fareva Holding Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 68. AbbVie Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 69. Nipro Corp Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 70. Vetter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 71. Sopharma Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 72. Mylan (DPT Laboratories) Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 73. Recipharm Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 74. NextPharma Technologies Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 75. Dishman Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 76. Aesica Revenue Growth Rate in Pharmaceutical Products and CMO Business (2016-2021)
    Figure 77. Bottom-up and Top-down Approaches for This Report
    Figure 78. Data Triangulation
    Figure 79. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma Technologies
Dishman
Aesica
Frequently Asked Questions
Pharmaceutical Products and CMO report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Pharmaceutical Products and CMO report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Pharmaceutical Products and CMO report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports